Texting your way to better health: WhatsApp trial for stroke and diabetes

NCT ID NCT07207694

Not yet recruiting Disease control Sponsor: Gaziler Physical Medicine and Rehabilitation Education and Research Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether adding WhatsApp-based education and counseling to standard care helps stroke patients with type 2 diabetes improve their lifestyle, blood sugar control, and disease knowledge. 84 participants will be split into two groups: one gets routine education, the other also gets a four-week WhatsApp program with videos, booklets, and direct messaging support. Researchers will measure changes in diabetes knowledge, healthy behaviors, and blood sugar levels after six months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: WhatsApp-based education and counseling
What this could lead to: If it works, this could show that simple smartphone messaging helps stroke patients with diabetes better manage their health and blood sugar.
What could go wrong: This is a small, early-stage trial with only 84 people. The results may not apply to everyone, and the benefit may be small or hard to measure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ischemic stroke stroke disorder type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

STROKE TYPE 2 DIABETES MELLITUS (T2DM)

More trials for these conditions

Other studies related to the condition(s) this trial covers.